ViRexx Medical Corp. (TSX:VIR) (AMEX: REX), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that Lorne Tyrrell, Chief Executive Officer and Chief Scientific Officer of ViRexx, is scheduled to present at the upcoming Rodman & Renshaw Techvest Seventh Annual Healthcare Conference. The presentation is scheduled for 9:05 a.m. local time (3:05 a.m. Eastern Time) on Monday, May 15, 2006. The event will be held from May 14 - May 16, 2006 at the Le Meridien Sea Club in Monte Carlo, Monaco.
